Dr. Tom Van Der Hulle

This study is testing a new way to take the kidney cancer drug cabozantinib. Researchers want to see if taking a higher dose for one or two days, then skipping a day, works as well as taking a smaller dose every single day. They are checking if this new schedule keeps enough medi…